Buccoadhensive drug delivery systems - Extensive review on recent patents

Recent Patents on Drug Delivery and Formulation

Volumn 2, Issue 2, 2008, Pages 177-188

  Pathan, Shadab A ^a   Iqbal, Zeenat ^a   Sahani, Jasjeet K ^a   Talegaonkar, Sushma ^a   Khar, Roop K ^a   Ahmad, Farhan J ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bioadhensive polymers; Buccal drug delivery; Buccal films; Buccal gel; Buccal ointments; Buccal patches; Buccal patents; Buccaodhesion

Indexed keywords

ACRYLIC ACID; BUPRENORPHINE; CARBOMER; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; COPOLYMER; CYCLODEXTRIN DERIVATIVE; DRUG CARRIER; ESTRADIOL; GLYCERYL TRINITRATE; GONADORELIN; HYDRALAZINE; ISOSORBIDE DINITRATE; KARAYA GUM; LIDOCAINE; MACROGOL; MICONAZOLE NITRATE; NANOPARTICLE; NIMESULIDE; POLY(METHYL METHACRYLATE); POLYACRYLIC ACID; POLYLACTIC ACID; POLYMER; PROPRANOLOL; RETINOL; SURFACTANT; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VERAPAMIL; XANTHAN; ADHESIVE AGENT; DRUG; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ACIDITY; APHTHOUS STOMATITIS; AQUEOUS SOLUTION; BIODEGRADABILITY; BUCCAL DRUG ADMINISTRATION; CHEEK MUCOSA; COLLOID; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; FIRST PASS EFFECT; GINGIVITIS; HUMAN; HYDROGEL; HYDROPHOBICITY; LOZENGE; MOUTH HYGIENE; MOUTH INJURY; MOUTH ULCER; MOUTHWASH; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE; TABLET FORMULATION; TREATMENT DURATION; BIOAVAILABILITY; CHEMISTRY; METABOLISM; METHODOLOGY; MOUTH MUCOSA; PHYSIOLOGY; SALIVARY GLAND; SOLUBILITY;

ADHESIVES; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, BUCCAL; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; POLYMERS; SALIVARY GLANDS; SOLUBILITY;

EID: 55849116385     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221108784534135     Document Type: Review

References (69)

1. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci 1998; 1(1): 15-30.
2. Raj B, Ravichandran M, Li X, Jasti BR. Advances in buccal drug delivery. Crit Rev Ther Drug Carrier Syst 2005; 22 (3):295-330.
3. Miller-Salamat N, Chittchang M, Johnston PT. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Dev Rev 2005; 57 (11): 1666-1691.
4. Mundschenk, D.D.: US20070014735 (2007).
5. Wani SM, Parekh SR, Dehgan MH, Polshettiwar SA, Chopade VV, Pande VV. Current status in buccal drug delivery. Available Online 28 April 2007 at www.pharmainfo.net
6. Bandyopadhyay AK, Sudhakar Y. Advances in buccal adhesive drug delivery. Drug Dev Technol 2006; 6(6): 51-55.
7. Hao J, Paul W, Heng S. Buccal delivery systems. Drug Dev Ind Pharm 2003; 29(8): 821-832.
8. John D. Smart drug delivery using buccal-adhesive systems. Adv Drug Dev Rev 1993; 11:253-270.
9. Gilles P, Ghazali FA, Rathbone J (ed.). Systemic oral mucosal drug delivery system and delivery systems; In: Oral mucosal drug delivery. New York, Marcel Dekker Inc 1996; 241-285.
10. Available at www.atrixlab.com
11. Nagai T. Topical mucosal adhesive dosage forms. Med Res Rev 1986; 6 (2): 227-242.
12. Yukimatsu K. Development of a transmucosal controlled-release device for systemic delivery of anti anginal drugs pharmacokinetics and pharmaco-dynamics. Drug Develop Ind Pharm 1994; 20(4): 503-534.
13. Collins AE, Deasy PB. Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride. J Pharm Sci 1990; 79(2): 116.
14. Rajesh K, Agarwal SP, Ahuja A. Preparation and evaluation of bioerodible buccal tablets containing clotrimazole. Int J Pharm 1996; 138(1): 67-73.
15. Gupta A, Garg S, Khar RK. Interpolymer complexation and its effect on bioadhesion strength and dissolution characteristics of buccal drug delivery systems. Drug Develop Ind Pharm 1994; 20: 315-325.
16. Hsiao, C.H., Cacace, J.L.: US4755386 (1988).
17. Place, V.A.: US20006117446 (2000).
18. Pather, S.I., Khankari, R.K., Eichman, J.D., Robinson, J.R., Hontz, J.: US20016200604 (2001).
19. Acharya, R.N., Baker, J.L.: US20010051186 (2001).
20. Place, V.A.: US20016180682 (2001).
21. Place, V.A.: US20016284263 (2001).
22. Lerner, E.I., Flashner-Barak, M., Rosenberger, V.: US20040122065 (2004).
23. Shah, Y.: US20060068004 (2006).
24. Grodberg, M.G., Baylink, D. J.: US5039526 (1991).
25. Anders R, Merckle H. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm 1989; 49:231-240.
26. Cassidy JP, Landzert NM, Quodros E. Controlled buccal delivery of buprenorphine. J Control Release 1993; 25:21-29.
27. Danjo K, Kato H, Otsuka A, Ushimaru K. Fundamental study on the evaluation of strength of granular particles. Chem Pharm Bull 1994; 42: 2598-2603.
28. Degrande G, Benes L, Horriere F, et al. Specialized oral mucosal drug delivery systems: patches; In: Rathbone MJ, (Ed). Oral Mucosal Drug Deliv 1996; 285-318.
29. Ishida M, Nambu N, Nagai T. Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol. Chem Pharm Bull 1982; 30: 980-989.
30. Noha A, Nafee FA, Ismail NA, Boraie L, Mortada M. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of aging. Int J Pharm 2003; 264(1-2):1-14.
31. Anders R, Merckle HP, Schurr W, Ziegler R. Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin. J Pharm Sci 1983; 72:1481-1483.
32. Sanvordeker, D.R., Leung, S.-H.S.: US4900552 (1990).
33. Flockhart, I.R., Cort, J.H.: US5298256 (1994).
34. Liao, W.-C., Kydonieus, A.S., Kishore, R.: US5827525 (1998).
35. Madhat, M.N.: US20016264974 (2001).
36. Heiber, S.J., Ebert, C.D., Gutniak, M.K.: US5766620 (1998).
37. Dugger, III H.A.: US20006110486 (2000).
38. Modi, P.: US200263759753 (2002).
39. Mundschenk, D.D.: US20070014735 (2007).
40. Chien YW. Systemic delivery of peptide based formulation; In: Novel drug delivery system. New York, Marcel Dekker Inc1992; 677-678.
41. Madhat, M.N.: US20016264974 (2001).
42. Repka, M.A., Gerding, T.G.: US5714165 (1998).
43. Bremecker KD, Strempel H, Klein G. Novel concept for a mucosal adhesive ointment. J Pharm Sci 1984; 73:548-552.
44. Kitano M, Mitani Y, Takayama K, Nagai T. Buccal absorption of golden hamsters cheek in vitro and in vivo of 17-estradiol from hydrogels containing three types of enhancers. Int J Pharm1998; 174:19-28.
45. Watanabe K, Yakou S, Takayama K, Machida Y, Nagai T. Drug release behavior from hydrogel prepared with water dietary fibres. J Pharm Sci Techn Jpn1991; 51:29-35.
46. Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Dev Rev 1994; 13: 1-22.
47. Guenchidi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microsphere. Eur J Pharm Biopharm 2002; 53: 233-239.
48. Rudnic EM, Schwartz JD. Oral solid dosage forms. In: A. R. Gennaro (Ed.), Remington: The science and Practice of Pharmacy 2000; 858-859.
49. Gunther, R.E.: US4243655 (1981).
50. White, M.J.E.: US4554154 (1985).
51. Simone, A.J., Hefferren, J.J., Hand, M.S., Huber, G.: US5296209 (1994).
52. Lee, W.H.: US5437872 (1995).
53. Mody, S.S.B., Mody, P.D., Doshi, M.M.: US20006017516 (2000).
54. Doshi, M.M., Joshi, M.D., Mehta, B.P.: US20026365131 (2002).
55. Sagel, P.A., Dirksing, R.S., Rohman, F.J., Majeti, S., Reno, E.A.: US20006096328 (2000).
56. Chung, C.P.: US5599553 (1997).
57. Masterman, T.C., Spencer, J.L.: US6007795 (1999).
58. Lee, J.Y., Seo, M.H., Choi, I.J., Kim, J.H., Pai, C.M.: US20016193994 (2001).
59. Shefer, A., Shefer, S.D.: US20036589562 (2003).
60. Shefer, A., Shefer, S.D.: US20036565873 (2003).
61. Aungst BJ. Oral mucosal permeation enhancement: possibilities and limitations, in: Rathbone MJ (Ed.), oral mucosal drug delivery. Marcel Dekker, New York 1996; 65-83.
62. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci 2000; 89(4): 429-442.
63. Ebert, C.D., Heiber, S.J., Gutniak, M.K.: US5849322 (1998).
64. Mathias, N.R.: WO05115339 (2005).
65. Kost, J., Langer R.S.: US4948587 (1990).
66. Barclay, B.L., Childers, J.D., Wright, J., Place, V. A., Wong, P.S.L.: US5053032 (1991).
67. Britton, P., Flanagan, P., Hart, W.P., Linkin, D.: US5650192 (1997).
68. Nisonoff, K.: US20006103257 (2000).
69. Katz, H.S.: US20016326022 (2001).